Lower Levels of Alpha-synuclein not better for Parkinson’s Disease: Implications for Vaccines
In a study just published from the University of Chicago and Mayo clinic, lower levels of alpha-synuclein (the protein deposited in the brain of Parkinson’s disease patients) seemed to be associated with more disability in Parkinson’s disease. Though there are potential methodological issues with the study, it raises the question…